Register to attend in person
Description
Using opioid industry documents to understand the marketing of addictive medications
Per capita opioid consumption rates in the United States are the highest in the world, resulted in almost 500,000 deaths from 1999-2019, and are driven by prescribing and dispensing practices. There is limited evidence explaining how pharmaceutical companies influenced patients, healthcare providers, and regulators in the US to believe that opioids were safe and non-addictive, which is needed to inform future regulatory actions and practice guidelines addressing other addictive pharmaceuticals.
About
Dr. Apollonio is a Professor in the Department of Clinical Pharmacy at the University of California, San Francisco. Her research considers the activities of industries implicated in the spread of non-communicable diseases, including tobacco, pharmaceuticals, cannabis, and food. Recent work includes identifying tobacco cessation strategies for vulnerable populations, understanding the scope of tobacco and cannabis co-use, assessing the spread of laws addressing new tobacco and cannabis delivery systems, and analysing the role of pharmaceutical companies in the opioid crisis. Her work has been published in journals in multiple disciplines, including law, medicine, pharmacy, political science, public health, and public policy.
Organised by
The Global Health Centre (GHC).
